Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
423.2 USD | -1.57% | +3.16% | +4.01% |
11:53am | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497 | MT |
10/05 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.01% | 11TCr | |
+11.45% | 11TCr | |
-12.60% | 2.23TCr | |
-3.70% | 2.19TCr | |
-6.03% | 1.86TCr | |
-35.21% | 1.81TCr | |
-10.43% | 1.7TCr | |
+3.07% | 1.37TCr | |
+37.03% | 1.24TCr | |
+285.87% | 797.79Cr |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Transcript : Vertex Pharmaceuticals Incorporated, Q3 2018 Earnings Call, Oct 24, 2018